132 related articles for article (PubMed ID: 25823398)
1. Glycinamide prevents MK-801-induced hyperactivity and deficits in object recognition memory in an animal model of positive and cognitive symptoms of schizophrenia.
Basurto E; Flores OG; Hoffman KL
Schizophr Res; 2015 Aug; 166(1-3):349-50. PubMed ID: 25823398
[No Abstract] [Full Text] [Related]
2. Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus).
Hoffman KL; Basurto E
Behav Brain Res; 2014 Sep; 271():203-11. PubMed ID: 24933188
[TBL] [Abstract][Full Text] [Related]
3. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
4. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Brown JW; Rueter LE; Zhang M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic prenatal MK-801 treatment on object recognition, cognitive flexibility, and drug-induced locomotor activity in juvenile and adult rat offspring.
Gallant S; Welch L; Martone P; Shalev U
Behav Brain Res; 2017 Jun; 328():62-69. PubMed ID: 28390877
[TBL] [Abstract][Full Text] [Related]
6. Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
Boulay D; Pichat P; Dargazanli G; Estenne-Bouhtou G; Terranova JP; Rogacki N; Stemmelin J; Coste A; Lanneau C; Desvignes C; Cohen C; Alonso R; Vigé X; Biton B; Steinberg R; Sevrin M; Oury-Donat F; George P; Bergis O; Griebel G; Avenet P; Scatton B
Pharmacol Biochem Behav; 2008 Nov; 91(1):47-58. PubMed ID: 18621075
[TBL] [Abstract][Full Text] [Related]
7. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
[TBL] [Abstract][Full Text] [Related]
8. The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801.
Kruk-Slomka M; Budzynska B; Slomka T; Banaszkiewicz I; Biala G
Neurotox Res; 2016 Nov; 30(4):658-676. PubMed ID: 27577742
[TBL] [Abstract][Full Text] [Related]
9. Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats.
Marszalek-Grabska M; Gibula-Bruzda E; Jenda M; Gawel K; Kotlinska JH
Brain Res; 2016 Jul; 1642():389-396. PubMed ID: 27085203
[TBL] [Abstract][Full Text] [Related]
10. Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia.
Karamihalev S; Prickaerts J; van Goethem NP
Behav Brain Res; 2014 Oct; 272():248-51. PubMed ID: 25036424
[TBL] [Abstract][Full Text] [Related]
11. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus.
Ertuğrul A; Ozdemir H; Vural A; Dalkara T; Meltzer HY; Saka E
Brain Res Bull; 2011 Feb; 84(2):144-50. PubMed ID: 21134422
[TBL] [Abstract][Full Text] [Related]
12. Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice.
Mutlu O; Ulak G; Celikyurt IK; Akar FY; Erden F; Tanyeri P
Pharmacol Biochem Behav; 2011 Oct; 99(4):557-65. PubMed ID: 21693127
[TBL] [Abstract][Full Text] [Related]
13. Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice.
Park SJ; Lee Y; Oh HK; Lee HE; Lee Y; Ko SY; Kim B; Cheong JH; Shin CY; Ryu JH
Neuropharmacology; 2014 Nov; 86():49-56. PubMed ID: 24997455
[TBL] [Abstract][Full Text] [Related]
14. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N
Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189
[TBL] [Abstract][Full Text] [Related]
15. Ameliorative effect of N-desmethylclozapine in animal models of social deficits and cognitive functions.
Maehara S; Okuda S; Ohta H
Brain Res Bull; 2011 Oct; 86(3-4):146-51. PubMed ID: 21855612
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Rogóż Z; Wąsik A; Lorenc-Koci E
Pharmacol Rep; 2018 Aug; 70(4):623-630. PubMed ID: 29885435
[TBL] [Abstract][Full Text] [Related]
17. Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Tao C; Yan W; Li Y; Lu X
Psychiatry Res; 2016 Oct; 244():266-72. PubMed ID: 27512913
[TBL] [Abstract][Full Text] [Related]
18. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
Nikiforuk A; Hołuj M; Kos T; Popik P
Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
[TBL] [Abstract][Full Text] [Related]
19. Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.
Gururajan A; Taylor DA; Malone DT
Behav Brain Res; 2011 Sep; 222(2):299-308. PubMed ID: 21458498
[TBL] [Abstract][Full Text] [Related]
20. The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats.
Rung JP; Carlsson A; Markinhuhta KR; Carlsson ML
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):833-9. PubMed ID: 15913873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
